China's BGI Genomics to seek $1b funding ahead of its IPO

China's BGI Genomics to seek $1b funding ahead of its IPO

Next-generation sequencers operate at BGI's five-storey facility in Hong Kong, China, on Monday, Sept. 19, 2011. Photographer: Natasha Khan/Bloomberg

BGI Genomics Co., the listed arm of the world’s biggest DNA-sequencing group, is seeking to raise about $1 billion selling a stake in its equipment unit ahead of a planned initial public offering of the business, people with knowledge of the matter said.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter